Stenocare A/S reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was DKK 0.807889 million compared to DKK 0.896486 million a year ago. Net loss was DKK 4.46 million compared to DKK 3.8 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 DKK | -2.26% | +8.00% | +70.08% |
06-17 | Stenocare A/S Expands into Canada | CI |
05-23 | Stenocare A/S Launches Next Generation Medical Cannabis Oil Product in Australia | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+70.08% | 11.49M | |
+29.99% | 5.68B | |
-31.99% | 3.61B | |
-0.59% | 3.11B | |
-24.15% | 2.65B | |
-9.23% | 2.33B | |
+42.55% | 1.89B | |
+44.37% | 1.49B | |
-11.29% | 1.46B | |
+42.86% | 1.37B |
- Stock Market
- Equities
- STENO Stock
- News Stenocare A/S
- Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2023